Customer concentration
Two customers accounted for most revenue in recent periods, so any loss or slowdown would materially hit sales and cash flow.
- Scope
- 2025 Q1 platform customers accounted for 70.8% and 17.4% of revenue
- Materiality
- high
Inuvo, Inc.
Inuvo, Inc. builds AI-driven advertising technology that helps brands, agencies, and large demand platforms identify likely buyers based on intent rather than consumer identity. Its proprietary IntentKey and related tools are used to plan, target, activate, and measure digital advertising across search, social, programmatic, video, audio, native, and display channels.
−5,2 %
74,5 %
−5,9 %
+2,9 %
0.64
0.64
| % | |
|---|---|
| Intent AI and audience modeling | 45% IntentKey and related AI tools that infer consumer interest and build targetable audiences. |
| Managed services for agencies and brands | 30% Campaign planning, activation, and optimization sold as a managed service or SaaS-like offering. |
| Platform integrations | 20% Services for large demand consolidators that prioritize scale, quality, and compliance. |
| Publishing and proprietary media assets | 5% Owned or controlled digital content and websites used to align ads with consumer traffic. |
Inuvo sells primarily to advertising demand-side customers: agencies, brands, trading desks, and large platform...
- Agencies & Brandsprimary
Buy managed or self-service AI tools to discover intent-based audiences and activate campaigns across digital channels.
- Platform customersprimary
Large consolidators of advertising demand that use Inuvo for scalable, compliant ad delivery and integrations.
- Publishers and media ownerssecondary
Provide inventory and traffic that Inuvo monetizes through ad placements and revenue-sharing arrangements.
- Brands and direct advertiserssecondary
Use Inuvo to reach consumers at the moment of intent and improve campaign efficiency and response rates.
Inuvo is headquartered in the United States and its business appears concentrated in U.S...
- •United States is the core operating and customer market
- •Revenue is tied to U.S.-based digital advertising demand
- •No country-level revenue split was disclosed in the excerpts
- •Operational exposure is driven by platform relationships, not geography
- •U.S. privacy and advertising regulation is a key operating factor
Inuvo’s strategy is to replace legacy audience targeting with intent-based AI that can operate in a privacy-constrained...
01
Expand adoption of IntentKey and AI-driven audience modelingmedium-term
This is the core differentiator and the main path to durable pricing power.
02
Broaden platform and distribution relationshipsshort-term
Revenue is concentrated, so adding and retaining partners reduces customer risk.
03
Improve compliance, quality, and fraud controlsshort-term
Advertising performance and trust depend on accurate traffic and compliant delivery.
Inuvo is highly exposed to customer concentration, with a small number of platform customers accounting for most...
Platform policy and budget changes
Revenue depends on upstream advertising platforms and their rules, inventory depth, and ad pricing.
- Scope
- Changes in policies and procedures at a platform client already reduced revenue in 2025
- Materiality
- high
Click fraud and invalid traffic
The company shares revenue with publishers and may not recover funds tied to fabricated clicks.
- Scope
- Publisher monetization and traffic acquisition economics
- Materiality
- high
Privacy and regulatory change
The business model relies on targeting and measurement in a tightening privacy environment.
- Scope
- U.S. and other jurisdictional privacy laws
- Materiality
- medium
Cybersecurity and service interruption
A disruption could impair ad delivery, data integrity, and customer relationships.
- Scope
- Cloud, data, and advertising technology infrastructure
- Materiality
- medium
Revenue recognition for ad placements
Net revenue and quarterly comparability
Capitalized software development costs
Operating expenses, investing cash flow, and asset values
Goodwill and intangible asset impairment
Potential non-cash write-downs
Stock-based compensation
Operating loss and diluted share count
INOVIO PHARMACEUTICALS, INC.
INO · Pharmaceutical Preparations
INOVIO Pharmaceuticals is a clinical-stage biotechnology company developing DNA medicines designed to help treat and protect people from HPV-associated diseases, cancer, and infectious diseases.
Innoviva, Inc.
INVA · Pharmaceutical Preparations
INVO Fertility, Inc.
IVF · Surgical & Medical Instruments & Apparatus
InnovAge Holding Corp.
INNV · Services-Health Services
Innventure, Inc.
INV · Blank Checks
INTRUSION INC
INTZ · Computer Communications Equipment
: 28.4.2026